Neuroone Medical Technologies (NMTC) Convertible Debt (2017 - 2020)

Neuroone Medical Technologies (NMTC) has 4 years of Convertible Debt data on file, last reported at $1.0 million in Q3 2020.

• For the quarter ending Q3 2020, Convertible Debt changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2020 stood at $1.0 million (changed N/A YoY), and the FY2020 full-year result was $1.0 million, changed N/A from the prior year.
• Convertible Debt for Q3 2020 stood at $1.0 million, down from $6.7 million in the prior quarter.
• Across five years, Convertible Debt topped out at $6.7 million in Q2 2020 and bottomed at $1.0 million in Q3 2020.
• The 4-year median for Convertible Debt is $2.1 million (2018), against an average of $3.0 million.
• The widest annual swing landed in 2018, when Convertible Debt decreased 23.54%; it then jumped 213.2% in 2019.
• A 4-year view of Convertible Debt shows it stood at $2.2 million in 2017, then fell by 23.54% to $1.7 million in 2018, then surged by 213.2% to $5.2 million in 2019, then plunged by 80.6% to $1.0 million in 2020.
• The last three Convertible Debt figures came in at $1.0 million (Q3 2020), $6.7 million (Q2 2020), and $4.9 million (Q1 2020), per Business Quant data.

Peer Comparison